Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to access life-changing weight loss medications.

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...

April Wilkerson builds a DIY pot and pan pullout to improve cabinet access and organization.

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and provide more health benefits.

One comes mixed with tirzepatide, the active ingredient in Eli Lilly's Zepbound ... It did not respond to Reuters' inquiries, and blocked access to the forum after receiving them. It has a website ...

Lilly’s tirzepatide shortage ended first, with the FDA officially declaring the situation resolved early last October. The regulator erased Novo’s semaglutide from its shortage list in February.